(SMMT) Summit Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Summit Therapeutics | (SMMT) share price targets
Complete technical analysis of Summit Therapeutics (SMMT) by charts plus indicators, forecast predictions and share price targets for Summit Therapeutics (SMMT)
Summit Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-04 View latest technical analysis
10 day averaged volume of Summit Therapeutics is 2235540
Date | Daily Closing Price | Open | High | Low | Volume |
04 Mon Nov 2024 | 19.96 | 19.41 | 20.56 | 18.80 | 0.858 times |
01 Fri Nov 2024 | 18.99 | 18.98 | 19.77 | 18.61 | 1.031 times |
31 Thu Oct 2024 | 18.59 | 18.75 | 19.42 | 18.10 | 1.023 times |
30 Wed Oct 2024 | 18.65 | 21.00 | 21.18 | 18.60 | 1.745 times |
29 Tue Oct 2024 | 21.83 | 21.76 | 22.30 | 21.11 | 1.037 times |
28 Mon Oct 2024 | 22.24 | 21.41 | 22.90 | 21.26 | 1.218 times |
25 Fri Oct 2024 | 21.26 | 19.69 | 21.54 | 19.68 | 1.132 times |
24 Thu Oct 2024 | 19.46 | 20.06 | 20.75 | 19.43 | 0.635 times |
23 Wed Oct 2024 | 20.03 | 20.41 | 20.57 | 19.34 | 0.943 times |
22 Tue Oct 2024 | 20.59 | 20.41 | 20.91 | 20.20 | 0.447 times |
My analysis of stock is bearish for shortterm, and stock might move down till 19 or till 17.5. Use a stoploss of 20.38 and if the stock hits stoploss, then it can shoot up till 21.71
Share price targets for Summit Therapeutics (SMMT)
Target Type | Value |
Downside Target | 6.78 |
Downside Target | 8.88 |
Downside Target | 11.76 |
Downside Target | 14.25 |
Downside Target | 18.10 |
Downside Target | 19.34 |
Upside Target | 20.18 |
Upside Target | 20.56 |
Upside Target | 22.19 |
Upside Target | 22.90 |
Upside Target | 24.56 |
Upside Target | 33.89 |
Intraday share price targets for Summit Therapeutics (SMMT)
Target Type | Value |
Downside Intraday Target | 18.99 |
Downside Intraday Target | 18.01 |
Upside Intraday Target | 20.75 |
Upside Intraday Target | 21.53 |
Downside Intraday Target | 19.77 |
Weekly technical analysis of Summit Therapeutics (SMMT)
Date | Weekly Closing Price | Open | High | Low | Volume |
04 Mon Nov 2024 | 19.96 | 19.41 | 20.56 | 18.80 | 0.142 times |
01 Fri Nov 2024 | 18.99 | 21.41 | 22.90 | 18.10 | 1.534 times |
25 Fri Oct 2024 | 21.26 | 21.16 | 22.19 | 19.34 | 0.553 times |
18 Fri Oct 2024 | 21.21 | 19.55 | 24.56 | 19.55 | 1.35 times |
11 Fri Oct 2024 | 19.95 | 19.25 | 20.18 | 18.27 | 0.487 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Summit Therapeutics (SMMT)
Date | Monthly Closing Price | Open | High | Low | Volume |
04 Mon Nov 2024 | 19.96 | 18.98 | 20.56 | 18.61 | 0.061 times |
31 Thu Oct 2024 | 18.59 | 21.63 | 24.56 | 18.10 | 0.31 times |
30 Mon Sep 2024 | 21.90 | 12.98 | 33.89 | 11.76 | 5.769 times |
30 Fri Aug 2024 | 12.98 | 10.84 | 14.25 | 8.88 | 0.792 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Summit Therapeutics (SMMT)
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Summit Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Summit Therapeutics in short term but the sell signal is initial and weak.
Summit Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Summit Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Summit Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 20.11 and Summit Therapeutics (SMMT) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Summit Therapeutics (SMMT) stock. Volume based technical analysis of Summit Therapeutics (SMMT) stock is negative.
Summit Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Summit Therapeutics ( (SMMT) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Summit Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Summit Therapeutics in short term but the sell signal is initial and weak.
Summit Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Summit Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Summit Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 20.11 and Summit Therapeutics (SMMT) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Summit Therapeutics (SMMT) stock. Volume based technical analysis of Summit Therapeutics (SMMT) stock is negative.
Summit Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.